Embrace Release & Relief By relaxing your trigger point, the injection improves blood flow and reduces inflammation, giving many patients immediate and lasting relief

Pemetrexed for Injection, USP Brand Name Equivalent: Alimta Pemetrexed for Injection, USP 100 mg per vial Unit of Sale NDC 71288-166-10 Unit of Use NDC 71288-166-10 Container Type SD Glass Vial Strength 100 mg per vial Concentration N/A Fill Volume N/A Vial Size 10 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Case (108 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated Pemetrexed for Injection, USP 500 mg per vial Unit of Sale NDC 71288-167-50 Unit of Use NDC 71288-167-50 Container Type SD Glass Vial Strength 500 mg per vial Concentration N/A Fill Volume N/A Vial Size 50 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Case (108 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated Pemetrexed for Injection, USP 750 mg per vial Unit of Sale NDC 71288-147-50 Unit of Use NDC 71288-147-50 Container Type SD Glass Vial Strength 750 mg per vial Concentration N/A Fill Volume N/A Vial Size 50 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Pack (1 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated Pemetrexed for Injection, USP 1 g per vial Unit of Sale NDC 71288-148-51 Unit of Use NDC 71288-148-51 Container Type SD Glass Vial Strength 1 g per vial Concentration N/A Fill Volume N/A Vial Size 100 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Pack (1 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated The brands mentioned here are the trademarks of their respective owners

Fast Delivery
This affordable supplement is designed to fulfill the body's nutritional needs and is safe for long-term use
If you want consistent weight loss, MIC B12 injections will need to be given regularly
We are pleased to have been involved in producing the new guideline, and we will be participating in producing a new Guideline on the Treatment of Cobalamin and Folate Disorders later this year.